long intergenic non-protein coding RNA 1204Genealiases: []
Q-omics provides the consensus-scored LINC01204 profile across patient tissues and cancer cell-line models. LINC01204 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC01204 is differentially expressed in 7, with the highest sampling consensus in THCA. Additionally, LINC01204 RNA expression shows 8,353 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRC, THCA, and TGCT as cancer lineages where LINC01204 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01204 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01204 survival associations across molecular data types. LINC01204 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01204 RNA expression–survival associations across cancer types. High LINC01204 expression shows unfavorable associations in KIRC, KICH, MESO, UCS and KIRP, but favorable associations in SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC01204 RNA expression.
This table summarizes LINC01204 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01204. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01204 shows lower tumor expression in BRCA, PRAD and UCEC and higher tumor expression in THCA, HNSC and LUAD. The THCA box plot shows higher LINC01204 RNA expression in tumor versus normal tissue (log2 FC = +0.073, t-test p < 0.001).
This table shows molecular features associated with LINC01204 in patient tissues and cancer cell lines. In patient samples, LINC01204 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
